Bariatric surgery of T2DM:evidence and position

JI Li-nong

DOI: https://doi.org/10.3969/j.issn.1006-6187.2012.04.001

2012-01-01

Abstract:Obesity is the main drive factor of the development of T2DM as well as the main cause of increased T2DM prevalence.Recent studies showed that bariatric surgery could effectively prevent T2DM and could bring long-term remission in type 2diabetes through improving insulin sensitivity and β cell function.In a recent meta-analysis,bariatric surgery was associated with a 76.8%completed remission rate of diabetes(HbA 1 c<6% with normal FPG);a HbA 1 c reduction of 2.4%.It was also associated with a high rate amelioration of hyperlipidemia,hypercholesterolemia and hypertriglyceridemia(83%,86%and 92%,respectively);while the mortality related to diabetes decreased 14%.Researches showed that GLP-1 secretion increased after bariatric surgery,however,it may be just one of the mechanisms.Since 2008,bariatric surgery has been highly thought by the academic organizations and medical centers,and related guidelines and consensus have been enacted and published.Chinese Diabetes Society(CDS) and Chinese Surgical Society(CSS) had written and published Consensus on surgical treatment of diabetes mellitus,too.Bariatric surgery is now acknowledged as a proper therapy choice for T2DM patients with BMI≥ 35kg / m 2.In conclusion,treatment of diabetes with bariatric surgery is as important as the discovery of insulin with epoch-making significance for diabetes therapy.Further studies on mechanism of bariatric surgery for T2DM therapy will finally trigger major breakthrough of the research and development of pharmacotherapy for T2DM.